As used in NRS 439B.600 to 439B.695, inclusive, unless the context otherwise requires, the words and terms defined in NRS 439B.605 to 439B.622, inclusive, have the meanings ascribed to them in those sections. (Added to NRS by 2007, 3137; A 2017, 4301; 2021, 3723)
“Manufacturer” has the meaning ascribed to it in 42 U.S.C. § 1396r-8(k)(5). (Added to NRS by 2017, 4297; A 2021, 3723)
“National Drug Code” means the numerical code assigned to a prescription drug by the United States Food and Drug Administration. (Added to NRS by 2021, 3722)
“Pharmacy” means every store or shop licensed by the State Board of Pharmacy where drugs, controlled substances, poisons, medicines or chemicals are stored or possessed, or dispensed or sold at retail, or displayed for sale at retail, or where prescriptions are compounded or dispensed. The term does not include an institutional pharmacy as defined in […]
“Pharmacy benefit manager” has the meaning ascribed to it in NRS 683A.174. (Added to NRS by 2017, 4297)
1. “Rebate” means a discount or concession that affects the price of a prescription drug which is provided by the manufacture of the drug to: (a) A third party; (b) A pharmacy benefit manager after the pharmacy benefit manager has processed a claim from a pharmacy, an institutional pharmacy, as defined in NRS 639.0085, or […]
“Third party” means: 1. An insurer, as that term is defined in NRS 679B.540; 2. A health benefit plan, as that term is defined in NRS 687B.470, for employees which provides coverage for prescription drugs; 3. The Public Employees’ Benefits Program established pursuant to subsection 1 of NRS 287.043; 4. A governing body of a […]
“Unit” has the meaning ascribed to it in 42 U.S.C. § 1395w-3a(b)(2)(B). (Added to NRS by 2021, 3723)
“Wholesale acquisition cost” means the manufacturer’s published list price for a prescription drug with a unique National Drug Code for sale to a wholesaler or any other person or entity that purchases the prescription drug directly from the manufacturer, not including any rebates or other price concessions. (Added to NRS by 2017, 4297; A 2021, […]
“Wholesaler” has the meaning ascribed to it in NRS 639.016. (Added to NRS by 2021, 3723)
The organization with the largest membership in this State which represents the interests of retail merchants, as determined by the Department, shall: 1. Prepare a list of not less than the 100 brand name prescription drugs or generic equivalents most commonly prescribed to residents of this State; and 2. At least once each calendar year, […]
1. On or before February 1 of each year, the Department shall compile: (a) A list of prescription drugs that the Department determines to be essential for treating diabetes in this State and the wholesale acquisition cost of each such drug on the list. The list must include, without limitation, all forms of insulin and […]
1. On or before April 1 of each year, the manufacturer of a prescription drug that appears on either or both of the most current lists compiled by the Department pursuant to paragraphs (a) and (c) of subsection 1 of NRS 439B.630 shall prepare and submit to the Department, in the form prescribed by the […]
1. On or before April 1 of a year in which a drug is included on either or both of the lists compiled pursuant to paragraph (b) or (c) of subsection 1 of NRS 439B.630, the manufacturer of the drug shall submit to the Department: (a) A report describing the reasons for the increase in […]
1. On or before April 1 of each year, a wholesaler that sells a prescription drug that appears on either or both of the most current lists compiled by the Department pursuant to paragraphs (a) and (c) of subsection 1 of NRS 439B.630 for use in this State shall prepare and submit to the Department, […]
1. On or before April 1 of each year, a pharmacy benefit manager shall submit to the Department: (a) A report which includes the information prescribed by subsection 2; and (b) A statement signed under penalty of perjury affirming the accuracy of the information in the report. 2. The report submitted pursuant to paragraph (a) […]
On or before June 1 of each year, the Department shall: 1. Analyze the information submitted pursuant to NRS 439B.635 to 439B.645, inclusive, and compile a report on the price of prescription drugs. The report: (a) Must include, without limitation, a separate analysis of the information reported by manufacturers, pharmacy benefit managers and wholesalers, the […]
1. Except as otherwise provided in subsections 2 and 3, each pharmacy shall, in accordance with the regulations adopted pursuant to NRS 439B.685, provide to the Department: (a) Information that a consumer may use to locate, contact or otherwise do business with the pharmacy, including, without limitation: (1) The name of the pharmacy; (2) The […]
1. A manufacturer of a prescription drug shall provide to the Department a list of each pharmaceutical sales representative who markets prescription drugs on behalf of the manufacturer to providers of health care licensed, certified or registered in this State, pharmacies or employees thereof, operators or employees of medical facilities or persons licensed or certified […]
1. On or before February 1 of each year, a nonprofit organization that advocates on behalf of patients or funds medical research in this State and has received a payment, donation, subsidy or anything else of value from a manufacturer, third party or pharmacy benefit manager or a trade or advocacy group for manufacturers, third […]
